Circ0014614-miR9-3p轴上调MEPs中ITGB1的表达并诱导MSC成骨化促进ET形成和发展
批准号:
82070133
项目类别:
面上项目
资助金额:
54.0 万元
负责人:
徐丹
依托单位:
学科分类:
骨髓增殖性肿瘤
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
徐丹
中文摘要
近年来发生驱动基因突变的干祖细胞重塑的肿瘤niche参与MPN发生发展受到关注,但突变的HSCs重塑微环境的原因和机制知道甚少。我们前期研究表明ET患者MEPs外泌体装运circ0014614出现障碍,富集于MEPs胞浆中,负调控与其结合的miR9-3p,上调ITGB1引起MEPs的异常增殖及凋亡减少,扩增的MEPs影响MCSs的成骨化。基于此我们提出假说circ0014614-miR9-3p轴上调ITGB1引起MEPs异常扩增,重塑niche,诱导MCSs成骨化及OBCs的异常扩增,促进ET的形成和发展。为验证假说我们将体外调变miR9-3p及ITGB1,深入探讨circ0014614-miR9-3p-ITGB1调控通路异常的MEPs与niche中基质细胞“互话”的机制,并构建基因敲除的MPN小鼠进行体内验证。本研究对探索ET诊断和治疗的新靶点具有重要研究意义。
英文摘要
Recent years there is increasing attention on the involvement of tumor niche with the reconstruction of stem progenitor cells harboring driver mutations, into the development and progression of MPN. However, little is known about the reason and mechanism of the reconstruction of micro-environment by HSCs with gene mutations.Our previous study showed that circ0014614, which plays as exosomes shipment in megakaryocyte-erythroid progenitors (MEPs), was abnormal in the patients with essentialthrombocythemia (ET). Circ0014614 enriched in the plasma of MEPs, negatively regulated miR9-3p, which combines with circ0014614. Circ-0014614- miRNA9-3paxis induced abnormal proliferation and decreasing apoptosis of MEPs by up-regulation of β1-integrins (ITGB1). In turn,increasing MEPs influenced the ossification of MCSs and the amplification of OBCs. Based on those, we hypothesize that circ-0014614- miRNA9-3p axis reconstructs niche to boost the ossification of MCSs by up-regulation of ITGB1 to induce abnormal amplification of MEPs.In order to verify our hypothesis, we are going to regulate miR9-3p and ITGB1 in MEPs in vitro, furtherly explore the mechanism of cross-talk of abnormal regulation of circ0014614-miR9-3p-ITGB1 pathway with stroma cell in niche, and then do the verification in vivo by establishment of a MPN mouse model with gene knockout. Aim of this study is to reveal the mechanism of reconstruction of niche by stem progenitor cells harboring mutated genes in ET. It has a significance in exploring new therapy targets in ET.
近年来发生驱动基因突变的干祖细胞重塑的肿瘤niche参与MPN发生发展受到关注,但突变的HSCs重塑微环境的原因和机制知道甚少。本研究对ET及正常对照骨髓来源外泌体高通量深度测序,测序结果进行生信分析并结合文献,选择差异性 circRNA:has-circ0001136、has-circ 0002360、has-circ0014614,临床样本验证提示以上三种差异 circRNA在ET中均表达下调,与测序结果一致,其中circ-0014614在ET中表达显著降低;体外实验及临床样本验证试验,确定ET中circ-0014614表达下调,通过circ 0014614/ miR-138-5p/caspase3调控轴导致caspase3表达下调,引起巨核细胞凋亡受损,最终导致骨髓巨核增生;采用CyTOF及单细胞测序探索ET患者肿瘤微环境中免疫细胞代谢模式及其与微环境间相互作用,发现ET患者骨髓微环境中单核细胞、NK细胞和DC细胞代谢酶表达较正常对照组有显著异常改变,单核细胞中PFKFB3和CD36显著上调,可能其与 ET 中分泌多种细胞因子、向破骨细胞分化等功能相关;NK细胞中氧化磷酸化基因下调;DC 细胞中氧化磷酸化相关代谢基因下调,可能与其抗原呈递功能及 IFN-Ⅰ分泌功能受抑有关。ET骨髓免疫细胞代谢失衡,通过多种途径影响免疫细胞功能,进一步导致ET疾病发生发展。本研究深入探讨骨髓微环境circ-0014614/ miR-138-5p/caspase3调控轴及免疫细胞代谢变化对ET发生和发展的影响,为诊断及治疗ET提供新的靶点。
IGF1R/PERK介导巨噬细胞内质网应激诱
导耐药FLT3-ITD+急性髓系白血病细胞自
噬的机制研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:徐丹
-
依托单位:
达沙替尼下调CMV活化的NKG2C+NK细胞PD-1表达和增强杀伤ph+白血病干细胞的机制研究
-
批准号:81870128
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2018
-
负责人:徐丹
-
依托单位:
国内基金
海外基金